Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.31 -0.13 (-0.64%)
As of: Oct 21, 2026 · 12:50 PM EDT

Acadia Pharmaceuticals (ACAD) Receivables (2016 - 2026)

Updated

Acadia Pharmaceuticals' Receivables was $150.64 million in Q2 2026, up 40.1% from $107.51 million a year earlier and up 11.3% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Receivables (2016 - 2026) Analysis & Trends

At the end of FY2025, Receivables at Acadia Pharmaceuticals came in at $121.46 million, up 23.0% from FY2024.

  • Receivables has now increased for three consecutive years, with a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
  • In earlier years, Receivables was $98.74 million in FY2024 (+0.5%), $98.27 million in FY2023 (+58.0%), $62.2 million in FY2022 (-3.4%) and $64.37 million in FY2021 (+33.4%).
  • The Q2 2026 figure marks the highest quarterly Receivables in data going back to Q2 2016.
  • Compared with a year earlier, Receivables has increased for 14 straight quarters, with growth averaging 16.3% over the last eight quarters.
  • The best year-over-year quarter for Receivables over five years was Q3 2023 (growth of 66.5%); the worst was Q3 2022 (a decline of 8.2%).
  • Per Business Quant data, ACAD's Receivables in the three quarters before Q2 2026 was $135.35 million (Q1 2026), $121.46 million (Q4 2025) and $115.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn 19.05 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn 13.82 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn 15.68 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn 5.06 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 12.49 Bn
10 Acadia Pharmaceuticals 3.49 Bn 12.34 Mn 279.64 Mn 150.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.64 Mn
Mar 31, 2026 135.35 Mn
Dec 31, 2025 121.46 Mn
Sep 30, 2025 115.85 Mn
Jun 30, 2025 107.51 Mn
Mar 31, 2025 105.74 Mn
Dec 31, 2024 98.74 Mn
Sep 30, 2024 98.21 Mn
Jun 30, 2024 103.70 Mn
Mar 31, 2024 94.70 Mn
Dec 31, 2023 98.27 Mn
Sep 30, 2023 92.80 Mn
Jun 30, 2023 81.85 Mn
Mar 31, 2023 65.92 Mn
Dec 31, 2022 62.20 Mn
Sep 30, 2022 55.73 Mn
Jun 30, 2022 67.95 Mn
Mar 31, 2022 62.71 Mn
Dec 31, 2021 64.37 Mn
Sep 30, 2021 60.70 Mn
API Access

Acadia Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ACAD&period=max&api_key=YOUR_API_KEY